KORU Medical Systems PE Ratio 2012-2025 | KRMD
Current and historical p/e ratio for KORU Medical Systems (KRMD) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. KORU Medical Systems PE ratio as of February 11, 2026 is 0.00.
| KORU Medical Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-11 | 4.56 | 0.00 | |
| 2025-09-30 | 3.83 | $-0.08 | 0.00 |
| 2025-06-30 | 3.58 | $-0.09 | 0.00 |
| 2025-03-31 | 2.54 | $-0.11 | 0.00 |
| 2024-12-31 | 3.85 | $-0.12 | 0.00 |
| 2024-09-30 | 2.73 | $-0.25 | 0.00 |
| 2024-06-30 | 2.65 | $-0.25 | 0.00 |
| 2024-03-31 | 2.36 | $-0.28 | 0.00 |
| 2023-12-31 | 2.46 | $-0.29 | 0.00 |
| 2023-09-30 | 2.70 | $-0.17 | 0.00 |
| 2023-06-30 | 3.45 | $-0.17 | 0.00 |
| 2023-03-31 | 4.22 | $-0.19 | 0.00 |
| 2022-12-31 | 3.57 | $-0.20 | 0.00 |
| 2022-09-30 | 2.23 | $-0.18 | 0.00 |
| 2022-06-30 | 2.53 | $-0.17 | 0.00 |
| 2022-03-31 | 2.86 | $-0.13 | 0.00 |
| 2021-12-31 | 3.00 | $-0.10 | 0.00 |
| 2021-09-30 | 2.85 | $-0.10 | 0.00 |
| 2021-06-30 | 4.63 | $-0.07 | 0.00 |
| 2021-03-31 | 3.52 | $-0.07 | 0.00 |
| 2020-12-31 | 6.02 | $-0.03 | 0.00 |
| 2020-09-30 | 7.22 | $-0.01 | 0.00 |
| 2020-06-30 | 8.98 | 0 | 0.00 |
| 2020-03-31 | 7.50 | $0.03 | 250.00 |
| 2019-12-31 | 6.53 | $0.02 | 326.50 |
| 2019-09-30 | 3.95 | $0.02 | 197.50 |
| 2019-06-30 | 2.88 | $0.01 | 288.00 |
| 2019-03-31 | 1.60 | $0.02 | 80.00 |
| 2018-12-31 | 1.65 | $0.02 | 82.50 |
| 2018-09-30 | 1.65 | $0.02 | 82.43 |
| 2018-06-30 | 1.38 | $0.01 | 138.00 |
| 2018-03-31 | 1.30 | 0 | 0.00 |
| 2017-12-31 | 1.25 | 0 | 0.00 |
| 2017-09-30 | 0.53 | 0 | 0.00 |
| 2017-06-30 | 0.47 | 0 | 0.00 |
| 2017-03-31 | 0.40 | 0 | 0.00 |
| 2017-02-28 | 0.42 | 0 | 0.00 |
| 2016-11-30 | 0.46 | 0 | 0.00 |
| 2016-09-30 | 0.46 | 0 | 0.00 |
| 2016-08-31 | 0.44 | 0 | 0.00 |
| 2016-06-30 | 0.49 | 0 | 0.00 |
| 2016-05-31 | 0.35 | 0 | 0.00 |
| 2016-02-29 | 0.57 | 0 | 0.00 |
| 2015-11-30 | 0.41 | 0 | 0.00 |
| 2015-08-31 | 0.38 | 0 | 0.00 |
| 2015-05-31 | 0.45 | 0 | 0.00 |
| 2015-02-28 | 0.40 | 0 | 0.00 |
| 2014-11-30 | 0.39 | 0 | 0.00 |
| 2014-08-31 | 0.33 | 0 | 0.00 |
| 2014-05-31 | 0.24 | 0 | 0.00 |
| 2014-02-28 | 0.21 | 0 | 0.00 |
| 2013-11-30 | 0.21 | 0 | 0.00 |
| 2013-08-31 | 0.22 | 0 | 0.00 |
| 2013-05-31 | 0.21 | 0 | 0.00 |
| 2013-02-28 | 0.21 | 0 | 0.00 |
| 2012-11-30 | 0.26 | 0 | 0.00 |
| 2012-08-31 | 0.21 | 0 | 0.00 |
| 2012-05-31 | 0.22 | 0 | 0.00 |
| 2012-03-31 | 0.25 | 0 | 0.00 |
| 2012-02-29 | 0.25 | 0 | 0.00 |
| 2011-12-31 | 0.26 | 0 | 0.00 |
| 2011-11-30 | 0.26 | 0 | 0.00 |
| 2011-09-30 | 0.28 | 0 | 0.00 |
| 2011-08-31 | 0.36 | 0 | 0.00 |
| 2011-06-30 | 0.36 | 0 | 0.00 |
| 2011-05-31 | 0.35 | 0 | 0.00 |
| 2011-03-31 | 0.18 | 0 | 0.00 |
| 2011-02-28 | 0.18 | 0 | 0.00 |
| 2010-12-31 | 0.13 | 0 | 0.00 |
| 2010-09-30 | 0.15 | 0 | 0.00 |
| 2010-06-30 | 0.16 | 0 | 0.00 |
| 2010-03-31 | 0.15 | 0 | 0.00 |
| 2009-12-31 | 0.19 | 0 | 0.00 |
| 2009-09-30 | 0.18 | 0 | 0.00 |
| 2009-06-30 | 0.19 | 0 | 0.00 |
| 2009-03-31 | 0.13 | 0 | 0.00 |
| 2008-12-31 | 0.18 | 0 | 0.00 |
| 2008-09-30 | 0.15 | 0 | 0.00 |
| 2008-06-30 | 0.18 | 0 | 0.00 |
| 2008-03-31 | 0.10 | 0 | 0.00 |
| 2007-12-31 | 0.19 | 0 | 0.00 |
| 2007-11-30 | 0.16 | 0 | 0.00 |
| 2007-09-30 | 0.19 | 0 | 0.00 |
| 2007-06-30 | 0.10 | 0 | 0.00 |
| 2007-03-31 | 0.04 | 0 | 0.00 |
| 2006-12-31 | 0.05 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.216B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.738B | 35.55 |
| Tempus AI (TEM) | United States | $9.941B | 0.00 |
| Doximity (DOCS) | United States | $5.129B | 21.79 |
| IRhythm Holdings (IRTC) | United States | $4.904B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.925B | 31.93 |
| Privia Health (PRVA) | United States | $2.684B | 167.85 |
| Hinge Health (HNGE) | United States | $2.602B | 0.00 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.980B | 32.76 |
| Omnicell (OMCL) | United States | $1.750B | 48.75 |
| Azenta (AZTA) | United States | $1.381B | 55.54 |
| Enovis (ENOV) | United States | $1.291B | 6.78 |
| Clover Health Investments (CLOV) | United States | $1.095B | 0.00 |
| Schrodinger (SDGR) | United States | $1.004B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.861B | 0.00 |
| Phreesia (PHR) | United States | $0.748B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.713B | 0.00 |
| Talkspace (TALK) | United States | $0.646B | 130.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.365B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.338B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Carlsmed (CARL) | United States | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.285B | 13.10 |
| CapsoVision (CV) | United States | $0.220B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.158B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.146B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 5.49 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |